Navigation Links
Microwave synthesis connects with the (quantum) dots

Materials researchers at the National Institute of Standards and Technology (NIST) have developed a simplified, low-cost process for producing high-quality, water-soluble "quantum dots" for biological research. By using a laboratory microwave reactor to promote the synthesis of the widely used nanomaterials, the recently published* NIST process avoids a problematic step in the conventional approach to making quantum dots, resulting in brighter, more stable dots.

Quantum dots are specially engineered nanoscale crystals of semiconductor compounds. The name comes from the fact that their infinitesimal size enables a quantum electronics effect that causes the crystals to fluoresce brilliantly at specific, sharply defined colors. Bright, stable, tiny and tunable across a broad spectrum of colors, quantum dots that are engineered to attach themselves to particular proteins have become a popular research tool in areas such as cancer research for detecting, labeling and tracking specific biomarkers and cells.

Making good quantum dots for biological research is complex. First a semiconductor compoundtypically a mixture of cadmium and seleniummust be induced to crystallize into discrete nanocrystals of just the right size. Cadmium is toxic, and the compound also can oxidize easily (ruining the effect), so the nanocrystals must be encapsulated in a protective shell such as zinc sulfide. To make them water soluble for biological applications, a short organic molecule called a "ligand" is attached to the zinc atoms. The organic ligand also serves as a tether to attach additional functional molecules that cause the dot to bind to specific proteins.

The accepted commercial method uses a high-temperature reaction (about 300 degrees Celsius) that must be carefully controlled under an inert gas atmosphere for the crystallization and encapsulation stages. An intermediate ligand material that can tolerate the high temperature is used to promote the crystallization process, but it must be chemically swapped afterwards for a different compound that makes the material water soluble. The ligand exchange stepas well as several variations on the processis known to significantly alter the luminescence and stability of the resulting quantum dots.

Seeking a better method, NIST researchers turned to microwave-assisted chemistry. Microwaves have been employed in a variety of chemical reactions to reduce the required times and temperatures. Working at temperatures half those of commercial processes, the group developed a relatively simple two-stage process that requires no special atmospheric conditions and directly incorporates the water-soluble ligand into the shell without an exchange step. Using commercially available starting materials, they have synthesized highly uniform and efficient quantum dots for a range of frequencies and shown them to be stable in aqueous solutions for longer than four months.


Contact: Michael Baum
National Institute of Standards and Technology (NIST)

Related medicine news :

1. ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies
2. MedWaves, Inc. Announces Receipt of United States Food and Drug Administration 510k Clearance to Market Its Patented Microwave Coagulation/Ablation System
3. Microwave treatments for enlarged prostate cause blood pressure surges
4. Herley Awarded $1 Million in Awards for Integrated Microwave Assemblies for U.S. Military Aircraft
5. Synthesis of natural molecule could lead to better anti-cancer drugs
6. Thomson Reuters Adds Routes of Synthesis Data to Its Newport Horizon Premium and Newport Vision Premium Solutions
7. Five Hospitals to Share Patient Data: ICW Connects Regional Medical Centers and University Facility
8. New Social Networking Website Connects Patients and Caregivers
9. AGD Advocacy Conference Connects General Dentists with Congress
10. Macerich Connects Women and Giving in Partnership with Step Up Womens Network
11. World Medical Tourism & Global Health Congress Connects Global Healthcare Providers with Global Insurance Companies
Post Your Comments:
Related Image:
Microwave synthesis connects with the (quantum) dots
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: